However, TNBC harbors relatively high numbers of tumor-infiltrating lymphocytes (TILs) [16–18], frequently expresses higher levels of PD-L1 [19–21] and has an elevated tumor mutational burden [22, 23] compared with other breast cancer subtypes. The gene discussed is CD274; the disease is breast cancer.